Ameliorative effect of apelin on streptozotocin-induced diabetes and its associated cardiac hypertrophyFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 9 June 2017

References

• K.ParmarA.PrajapatiS.PatelM.PatelB.PatelCardioprotective effect of lisinopril in streptozotocin induced type – II diabetic ratsActa Endocrinol (Buc)82012177188
   Web of Science ®Google Scholar
• V.PalmieriB.CapaldoC.RussoUncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluationDiabetes Res Clin Pract792008262268
   Web of Science ®Google Scholar
• K.YosukeJ.AnnA.MattiDiabetic cardiovascular disease induced by oxidative stressInt J Mol Sci1620152523425263
   Web of Science ®Google Scholar
• B.D.BetsyPathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipidDiabetes Spectrum212008160165
   Google Scholar
• M.RajeshP.MukhopadhyayS.BatkaiCannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathyJ Am Coll Cardiol56201021152125
   PubMed Web of Science ®Google Scholar
• S.P.SnehalK.G.RameshCardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in ratsPharmacogn Res32011239245
   Google Scholar
• L.A.MonasteroloStrategies in diabetic nephropathy: apelin is making its wayJ Physiol5922014423424
   Web of Science ®Google Scholar
• S.L.PitkinJ.MaguireT.I.BonnerA.P.DavenportInternational union of basic and clinical pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and functionPharmacol Rev622010331342
   PubMed Web of Science ®Google Scholar
• J.J.MaguireM.J.KleinzS.L.PitkinA.P.DavenportPyr1 Apelin-13 identified as the predominant apelin isoform in the human heart vasoactive mechanisms and inotropic action in diseaseHypertension542009598604
   PubMed Web of Science ®Google Scholar
• M.M.A.AbulmeatyS.A.AbdullahA.M.AlmajwalApelin is promising in management of diabetes complicating high fat diet induced obesity in ratsProg Nutr152013245254
   Web of Science ®Google Scholar
• L.V.DeguanL.I.HeningC.LinxiApelin and APJ, a novel critical factor and therapeutic target for atherosclerosisActa Biochim Biophys Sin452013527533
   Google Scholar
• C.DrayC.KnaufD.DaviaudApelin stimulates glucose utilization in normal and obese insulin-resistantMice Cell Metab82008437445
   PubMed Web of Science ®Google Scholar
• M.HabchiL.DuvillardV.CottetCirculating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic controlClin Endocrinol (Oxf)812014696701
   PubMed Web of Science ®Google Scholar
• C.MeralE.TascilarF.KarademirElevated plasma levels of apelin in children with type 1 diabetes mellitusJ Pediatr Endocrinol Metab232010497502
   Web of Science ®Google Scholar
• M.R.SeyyedK.BajestaniV.B.PatelW.WangG.Y.OuditTargeting the ACE2 and apelin pathways are novel therapies for heart failure: opportunities and challengesCardiol Res Practice2012 Article ID 823193) 11
   Google Scholar
• M.J.KleinzG.F.BaxterApelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinaseRegul Pept1462008271277
   PubMed Web of Science ®Google Scholar
• A.T.Abd ElmouttalebE.E.EbrahemK.A.MarghanyE.M.BayomyA.A.HassaboPlasma apelin concentrations in non-obese acute myocardial infarction patients with type 2 diabetes mellitusAm J Med Med Sci620165765
   Google Scholar
• V.L.LakomkinA.A.AbramovE.V.LukoshkovaThe action of apelin-12 and its analog on hemodynamics and cardiac contractile function of rats with isoproterenol-induced myocardial lesionKardiologiia5520155462
   Web of Science ®Google Scholar
• S.TerukiS.TakashiW.HiroyukiApelin is a positive regulator of ACE2 in failing heartsJ Clin Invest123201352035211
   Web of Science ®Google Scholar
• A.A.HamedH.A.MalekEffect of telmisartan in experimentally induced diabetetes mellitus in ratsInt J Health Sci120072
   Google Scholar
• B.J.GoudV.DwarakanathB.K.Chikka swamyStreptozotocin – a diabetogenic agent in animal modelsIjppr Human32015253269
   Google Scholar
• O.ChinedumK.EleazuE.ChinedumC.SoniaN.UdemeReview of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humansJ Diabetes Metab Disord12201360
   Google Scholar
• P.PalsamyS.SubramanianResveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocinnicotinamide induced experimental diabetic ratsBiomed Pharmacother47200818
   Google Scholar
• K.HiguchiT.MasakiK.GotohApelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in miceEndocrinology148200726902697
   PubMed Web of Science ®Google Scholar
• J.M.OlefskyInsulin resistance and insulin action. An in vitro and in vivo respectiveDiabetes301981118162
   Web of Science ®Google Scholar
• D.W.A.BourneFirst Course in Pharmacokinetics & Biopharmaceutics1995University of Oklahoma College of Pharmacy
   Google Scholar
• R.D.PurvesOptimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)J Pharmacokin Biopharm201992211227
   PubMedGoogle Scholar
• S.I.LulatY.C.YadavR.BalaramanR.MaheshwariAntiurolithiatic effect of lithocare against ethylene glycol-induced urolithiasis in Wistar ratsIndian J Pharmacol4820167882
   Web of Science ®Google Scholar
• Tietz NW, Cook T, McNiven MA. Clinical Guide to Laboratory Tests. WB Saunders Co; 1995:509–512.
   Google Scholar
• M.W.McgowanJ.D.ArtissD.R.StrandberghB.ZakA peroxidase-coupled method for the colorimetric determination of serum triglyceridesClin Chem291983538542
   PubMed Web of Science ®Google Scholar
• Saini AS, Taliyan R, Sharma PL. Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats. Pharmacogn Magasine. 2014;10:172–178.
   Google Scholar
• O.H.LowryN.J.RosenbroughA.L.FarrR.J.RandallProtein measurement with the Folin phenol reagentJ Biol Chem931951265275
   Google Scholar
• A.KhaidarM.MarxB.LubecG.L.LubecL-arginine reduces heart collagen accumulation in the diabetic db/db mouseCirculation901994479483
   Web of Science ®Google Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170.
   Google Scholar
• Aebi H. Oxidoreductases acting on groups other than CHOH: catalase. Methods in Enzymology. London 7: Academic Press 1984;105:121–25.
   Google Scholar
• M.S.MoronJ.W.DepierreB.MannervikLevels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochim Biophys Acta58219796778
   PubMed Web of Science ®Google Scholar
• T.F.SlaterB.C.SawyerThe stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro. General features of the systems usedJ Biochem1231971805814
   Web of Science ®Google Scholar
• B.SihemD.A.EvanDiabetic cardiomyopathy, causes and effectsRev Endocr Metab Disord1120103139
   Web of Science ®Google Scholar
• B.H.ZhangC.X.GuoH.X.WangCardioprotective effects of adipokine apelin on myocardial infarctionHeart Vessels292014679689
   Web of Science ®Google Scholar
• W.KoguchiN.KobayashiH.TakeshimaM.IshikawaF.SugiyamaT.IshmitsuCardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failureCirculation762012137144
   Web of Science ®Google Scholar
• I.Falcão-PiresA.F.Leite-MoreiraDiabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatmentHeart Fail Rev172012325344
   PubMed Web of Science ®Google Scholar
• S.XuP.HanM.HuangIn vivo, ex vivo, and in vitro studies on apelin’s effect on myocardial glucose UptakePeptides372012320326
   PubMed Web of Science ®Google Scholar
• C.AttanéD.DaviaudC.DrayApelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivoJ Mol Endocrinol4620112128
   PubMed Web of Science ®Google Scholar
• H.ChenC.ZhengX.ZhangJ.LiL.ZhengK.HuangApelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita micePeptides32201116341639
   Web of Science ®Google Scholar
• H.NakayamaT.MorozumiS.NantoAbnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heartJpn Circ652001783787
   Google Scholar
• A.ThanY.ChengL.C.FohApelin inhibits adipogenesis and lipolysis through distinct molecular pathwaysMol Cell Endocrinol3622012227241
   PubMed Web of Science ®Google Scholar
• G.M.Howard-AlpeJ.W.SearP.FoexMethods of detecting atherosclerosis in non cardiac surgical patients; the role of biochemical markersBrit J Anaesth972006758769
   PubMed Web of Science ®Google Scholar
• M.FuleshworA.PratikK.DeepakStudy of lipid profile and the effect of cardiac enzymes in type 2 diabetes mellitus patient developing coronary heart diseaseInt Res J Pharm App Sci320135154
   Google Scholar
• X.Y.LiuQ.LuX.P.OuyangApelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C a signaling in THP-1 macrophage-derived foam cellsAtherosclerosis2262013398407
   PubMed Web of Science ®Google Scholar
• Y.AziziM.FaghihiA.ImaniM.RoghaniA.NazariPost-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the ratmodel of myocardial infarctionPeptides4620137682
   PubMed Web of Science ®Google Scholar
• B.B.DokkenThe pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipidsDiabetes Spectrum212008160165
   Google Scholar
• G.G.WangW.LiX.H.LuX.ZhaoL.XuTaurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic ratsCroat Med J542013171179
   Web of Science ®Google Scholar
• I.G.PoornimaP.ParikhR.P.ShannonDiabetic cardiomyopathy: the search for a unifying hypothesisCir Res982006596
   PubMed Web of Science ®Google Scholar
• J.L.EvansI.D.GoldfineB.A.MadduxG.M.GrodskyAre oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes52200318
   PubMed Web of Science ®Google Scholar
• D.PchejetskiC.FoussalC.AlfaranoApelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1Eur Heart J33201223602369
   PubMed Web of Science ®Google Scholar
• C.R.BanS.M.TwiggFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersVasc Health Risk Manag42008575596
   PubMedGoogle Scholar
• M.KhullarA.A.Al-ShudiefatA.LudkeG.BinepalP.K.SingalOxidative stress: a key contributor to diabetic cardiomyopathyCan J Physiol Pharmacol882010233240
   PubMed Web of Science ®Google Scholar
• C.DuerrschmidJ.R.CrawfordE.ReinekeTNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosisJ Mol Cell Cardiol5720135967
   PubMed Web of Science ®Google Scholar
• X.ShenS.ZhengN.S.MetreveliP.N.EpsteinProtection of cardiac mitochondria by overexpression of Mn SOD reduces diabetic cardiomyopathyDiabetes552006798805
   PubMed Web of Science ®Google Scholar
• O.PisarenkoV.LankinG.KonovalovaApelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusionMol Cell Biochem3912014241
   Web of Science ®Google Scholar
• H.X.ZhangC.JiaojiaoS.TaoGW26-e0194 Apelin ameliorates myocardial insulin resistance and improves myocardial injury in diabetesJ Am Coll Cardiol66201520
   Web of Science ®Google Scholar